Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke

S. Claiborne Johnston,Jordan J. Elm,J. Donald Easton,Mary Farrant,William G. Barsan,Anthony S. Kim,Anne S. Lindblad,Yuko Y. Palesch,Karla G Zurita,Gregory W. Albers,Brett Cucchiara,Dawn Kleindorfer,Helmi L. Lutsep,Claire Pearson,Pramod Sethi,Nirali Vora

Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke

2019

S. Claiborne Johnston
Jordan J. Elm
J. Donald Easton
Mary Farrant
William G. Barsan
Anthony S. Kim
Anne S. Lindblad
Yuko Y. Palesch
Karla G Zurita
Gregory W. Albers
Brett Cucchiara
Dawn Kleindorfer
Helmi L. Lutsep
Claire Pearson
Pramod Sethi
Nirali Vora

Background: In patients with acute minor ischemic stroke or high-risk transient ischemic attack enrolled in the POINT trial (Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke [POINT...

Keywords:

Aspirin
Clopidogrel
Diabetes mellitus
Internal medicine
Platelet aggregation inhibitor
Stroke
Cardiology
Medicine
Proportional hazards model
Risk assessment
Pharmacotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations